APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plasma Fractionation Technology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plasma Fractionation Technology Market Outlook and Growth Opportunities 2026

Report ID 17421657048 January 2026206 pages

Choose your research edition.

Industry ResearchPlasma Fractionation Technology Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Fractionation Technology Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Plasma Fractionation Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Fractionation Technology Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Fractionation Technology Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Plasma Fractionation Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Fractionation Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasma Fractionation Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasma Fractionation Technology market include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Plasma Fractionation Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma Fractionation Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Fractionation Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasma Fractionation Technology market.

Plasma Fractionation Technology Segment by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Tiantan Bio

Shuanglin Bio

Boya Bio

Yuanda Shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Plasma Fractionation Technology Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Other

Plasma Fractionation Technology Segment by Application

Hospital

Retail Pharmacy

Other

Plasma Fractionation Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasma Fractionation Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasma Fractionation Technology key companies, revenue, market share, and recent developments.

3. To split the Plasma Fractionation Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasma Fractionation Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasma Fractionation Technology significant trends, drivers, influence factors in global and regions.

6. To analyze Plasma Fractionation Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Fractionation Technology industry.

Chapter 3: Detailed analysis of Plasma Fractionation Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasma Fractionation Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasma Fractionation Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasma Fractionation Technology Industry Trends Table 2. Plasma Fractionation Technology Industry Drivers Table 3. Plasma Fractionation Technology Industry Opportunities and Challenges Table 4. Plasma Fractionation Technology Industry Restraints Table 5. Global Plasma Fractionation Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasma Fractionation Technology Revenue Share by Company (2021-2026) Table 7. Global Plasma Fractionation Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasma Fractionation Technology Key Company Manufacturing Base & Headquarters Table 9. Global Plasma Fractionation Technology Company, Product Type & Application Table 10. Global Plasma Fractionation Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasma Fractionation Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Immune Globulin Table 15. Significant Companies of Coagulation Factor Table 16. Significant Companies of Albumin Table 17. Significant Companies of Other Table 18. Global Plasma Fractionation Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Plasma Fractionation Technology Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Plasma Fractionation Technology Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Plasma Fractionation Technology Sales Value Share by Type (2021-2026) Table 22. Global Plasma Fractionation Technology Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Retail Pharmacy Table 25. Significant Companies of Other Table 26. Global Plasma Fractionation Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plasma Fractionation Technology Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Plasma Fractionation Technology Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Plasma Fractionation Technology Sales Value Share by Application (2021-2026) Table 30. Global Plasma Fractionation Technology Sales Value Share by Application (2027-2032) Table 31. Global Plasma Fractionation Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plasma Fractionation Technology Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Plasma Fractionation Technology Sales Value Share by Region (2021-2026) Table 34. Global Plasma Fractionation Technology Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Plasma Fractionation Technology Sales Value Share by Region (2027-2032) Table 36. Global Plasma Fractionation Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Plasma Fractionation Technology Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Plasma Fractionation Technology Sales Value Market Share by Country (2021-2026) Table 39. Global Plasma Fractionation Technology Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Plasma Fractionation Technology Sales Value Market Share by Country (2027-2032) Table 41. Takeda Company Information Table 42. Takeda Business Overview Table 43. Takeda Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Takeda Plasma Fractionation Technology Product Portfolio Table 45. Takeda Recent Development Table 46. CSL Company Information Table 47. CSL Business Overview Table 48. CSL Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. CSL Plasma Fractionation Technology Product Portfolio Table 50. CSL Recent Development Table 51. Grifols Company Information Table 52. Grifols Business Overview Table 53. Grifols Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Grifols Plasma Fractionation Technology Product Portfolio Table 55. Grifols Recent Development Table 56. Octapharma Company Information Table 57. Octapharma Business Overview Table 58. Octapharma Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Octapharma Plasma Fractionation Technology Product Portfolio Table 60. Octapharma Recent Development Table 61. Kedrion Company Information Table 62. Kedrion Business Overview Table 63. Kedrion Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Kedrion Plasma Fractionation Technology Product Portfolio Table 65. Kedrion Recent Development Table 66. LFB Group Company Information Table 67. LFB Group Business Overview Table 68. LFB Group Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. LFB Group Plasma Fractionation Technology Product Portfolio Table 70. LFB Group Recent Development Table 71. Biotest Company Information Table 72. Biotest Business Overview Table 73. Biotest Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Biotest Plasma Fractionation Technology Product Portfolio Table 75. Biotest Recent Development Table 76. BPL Company Information Table 77. BPL Business Overview Table 78. BPL Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BPL Plasma Fractionation Technology Product Portfolio Table 80. BPL Recent Development Table 81. RAAS Company Information Table 82. RAAS Business Overview Table 83. RAAS Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. RAAS Plasma Fractionation Technology Product Portfolio Table 85. RAAS Recent Development Table 86. CBPO Company Information Table 87. CBPO Business Overview Table 88. CBPO Plasma Fractionation Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CBPO Plasma Fractionation Technology Product Portfolio Table 90. CBPO Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Hualan Bio Plasma Fractionation Technology Product Portfolio Table 95. Hualan Bio Recent Development Table 96. Tiantan Bio Company Information Table 97. Tiantan Bio Business Overview Table 98. Tiantan Bio Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Tiantan Bio Plasma Fractionation Technology Product Portfolio Table 100. Tiantan Bio Recent Development Table 101. Shuanglin Bio Company Information Table 102. Shuanglin Bio Business Overview Table 103. Shuanglin Bio Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Shuanglin Bio Plasma Fractionation Technology Product Portfolio Table 105. Shuanglin Bio Recent Development Table 106. Boya Bio Company Information Table 107. Boya Bio Business Overview Table 108. Boya Bio Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Boya Bio Plasma Fractionation Technology Product Portfolio Table 110. Boya Bio Recent Development Table 111. Yuanda Shuyang Company Information Table 112. Yuanda Shuyang Business Overview Table 113. Yuanda Shuyang Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Yuanda Shuyang Plasma Fractionation Technology Product Portfolio Table 115. Yuanda Shuyang Recent Development Table 116. Weiguang Bio Company Information Table 117. Weiguang Bio Business Overview Table 118. Weiguang Bio Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Weiguang Bio Plasma Fractionation Technology Product Portfolio Table 120. Weiguang Bio Recent Development Table 121. Nanyue Bio Company Information Table 122. Nanyue Bio Business Overview Table 123. Nanyue Bio Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Nanyue Bio Plasma Fractionation Technology Product Portfolio Table 125. Nanyue Bio Recent Development Table 126. KM Biologics Company Information Table 127. KM Biologics Business Overview Table 128. KM Biologics Plasma Fractionation Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. KM Biologics Plasma Fractionation Technology Product Portfolio Table 130. KM Biologics Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Plasma Fractionation Technology Product Image Figure 2. Global Plasma Fractionation Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Fractionation Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Fractionation Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Immune Globulin Image Figure 8. Coagulation Factor Image Figure 9. Albumin Image Figure 10. Other Image Figure 11. Global Plasma Fractionation Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Plasma Fractionation Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Plasma Fractionation Technology Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Retail Pharmacy Image Figure 16. Other Image Figure 17. Global Plasma Fractionation Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plasma Fractionation Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Plasma Fractionation Technology Sales Value Share by Application (2021-2032) Figure 20. Global Plasma Fractionation Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Plasma Fractionation Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Plasma Fractionation Technology Sales Value (2021-2032) & (US$ Million) Figure 23. North America Plasma Fractionation Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Plasma Fractionation Technology Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Plasma Fractionation Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Plasma Fractionation Technology Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Plasma Fractionation Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Plasma Fractionation Technology Sales Value (2021-2032) & (US$ Million) Figure 29. South America Plasma Fractionation Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Plasma Fractionation Technology Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Plasma Fractionation Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Plasma Fractionation Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Fractionation Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Fractionation Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasma Fractionation Technology Market Dynamics
  1. 2.1 Plasma Fractionation Technology Industry Trends
  2. 2.2 Plasma Fractionation Technology Industry Drivers
  3. 2.3 Plasma Fractionation Technology Industry Opportunities and Challenges
  4. 2.4 Plasma Fractionation Technology Industry Restraints
3 Plasma Fractionation Technology Market by Company
  1. 3.1 Global Plasma Fractionation Technology Company Revenue Ranking in 2025
  2. 3.2 Global Plasma Fractionation Technology Revenue by Company (2021-2026)
  3. 3.3 Global Plasma Fractionation Technology Company Ranking (2024-2026)
  4. 3.4 Global Plasma Fractionation Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasma Fractionation Technology Company Product Type and Application
  6. 3.6 Global Plasma Fractionation Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasma Fractionation Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasma Fractionation Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasma Fractionation Technology Market by Type
  1. 4.1 Plasma Fractionation Technology Type Introduction
  2. 4.1.1 Immune Globulin
  3. 4.1.2 Coagulation Factor
  4. 4.1.3 Albumin
  5. 4.1.4 Other
  6. 4.2 Global Plasma Fractionation Technology Sales Value by Type
  7. 4.2.1 Global Plasma Fractionation Technology Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Plasma Fractionation Technology Sales Value by Type (2021-2032)
  9. 4.2.3 Global Plasma Fractionation Technology Sales Value Share by Type (2021-2032)
5 Plasma Fractionation Technology Market by Application
  1. 5.1 Plasma Fractionation Technology Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Plasma Fractionation Technology Sales Value by Application
  6. 5.2.1 Global Plasma Fractionation Technology Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma Fractionation Technology Sales Value by Application (2021-2032)
  8. 5.2.3 Global Plasma Fractionation Technology Sales Value Share by Application (2021-2032)
6 Plasma Fractionation Technology Regional Value Analysis
  1. 6.1 Global Plasma Fractionation Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Fractionation Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasma Fractionation Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasma Fractionation Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Fractionation Technology Sales Value (2021-2032)
  7. 6.3.2 North America Plasma Fractionation Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasma Fractionation Technology Sales Value (2021-2032)
  10. 6.4.2 Europe Plasma Fractionation Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasma Fractionation Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasma Fractionation Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasma Fractionation Technology Sales Value (2021-2032)
  16. 6.6.2 South America Plasma Fractionation Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasma Fractionation Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasma Fractionation Technology Sales Value Share by Country, 2025 VS 2032
7 Plasma Fractionation Technology Country-level Value Analysis
  1. 7.1 Global Plasma Fractionation Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasma Fractionation Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasma Fractionation Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasma Fractionation Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasma Fractionation Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasma Fractionation Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasma Fractionation Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Plasma Fractionation Technology Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Plasma Fractionation Technology Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Plasma Fractionation Technology Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Plasma Fractionation Technology Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Plasma Fractionation Technology Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group Plasma Fractionation Technology Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Biotest
  38. 8.7.1 Biotest Company Information
  39. 8.7.2 Biotest Business Overview
  40. 8.7.3 Biotest Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biotest Plasma Fractionation Technology Product Portfolio
  42. 8.7.5 Biotest Recent Developments
  43. 8.8 BPL
  44. 8.8.1 BPL Company Information
  45. 8.8.2 BPL Business Overview
  46. 8.8.3 BPL Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BPL Plasma Fractionation Technology Product Portfolio
  48. 8.8.5 BPL Recent Developments
  49. 8.9 RAAS
  50. 8.9.1 RAAS Company Information
  51. 8.9.2 RAAS Business Overview
  52. 8.9.3 RAAS Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RAAS Plasma Fractionation Technology Product Portfolio
  54. 8.9.5 RAAS Recent Developments
  55. 8.10 CBPO
  56. 8.10.1 CBPO Company Information
  57. 8.10.2 CBPO Business Overview
  58. 8.10.3 CBPO Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CBPO Plasma Fractionation Technology Product Portfolio
  60. 8.10.5 CBPO Recent Developments
  61. 8.11 Hualan Bio
  62. 8.11.1 Hualan Bio Company Information
  63. 8.11.2 Hualan Bio Business Overview
  64. 8.11.3 Hualan Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Bio Plasma Fractionation Technology Product Portfolio
  66. 8.11.5 Hualan Bio Recent Developments
  67. 8.12 Tiantan Bio
  68. 8.12.1 Tiantan Bio Company Information
  69. 8.12.2 Tiantan Bio Business Overview
  70. 8.12.3 Tiantan Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tiantan Bio Plasma Fractionation Technology Product Portfolio
  72. 8.12.5 Tiantan Bio Recent Developments
  73. 8.13 Shuanglin Bio
  74. 8.13.1 Shuanglin Bio Company Information
  75. 8.13.2 Shuanglin Bio Business Overview
  76. 8.13.3 Shuanglin Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shuanglin Bio Plasma Fractionation Technology Product Portfolio
  78. 8.13.5 Shuanglin Bio Recent Developments
  79. 8.14 Boya Bio
  80. 8.14.1 Boya Bio Company Information
  81. 8.14.2 Boya Bio Business Overview
  82. 8.14.3 Boya Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boya Bio Plasma Fractionation Technology Product Portfolio
  84. 8.14.5 Boya Bio Recent Developments
  85. 8.15 Yuanda Shuyang
  86. 8.15.1 Yuanda Shuyang Company Information
  87. 8.15.2 Yuanda Shuyang Business Overview
  88. 8.15.3 Yuanda Shuyang Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Yuanda Shuyang Plasma Fractionation Technology Product Portfolio
  90. 8.15.5 Yuanda Shuyang Recent Developments
  91. 8.16 Weiguang Bio
  92. 8.16.1 Weiguang Bio Company Information
  93. 8.16.2 Weiguang Bio Business Overview
  94. 8.16.3 Weiguang Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Weiguang Bio Plasma Fractionation Technology Product Portfolio
  96. 8.16.5 Weiguang Bio Recent Developments
  97. 8.17 Nanyue Bio
  98. 8.17.1 Nanyue Bio Company Information
  99. 8.17.2 Nanyue Bio Business Overview
  100. 8.17.3 Nanyue Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nanyue Bio Plasma Fractionation Technology Product Portfolio
  102. 8.17.5 Nanyue Bio Recent Developments
  103. 8.18 KM Biologics
  104. 8.18.1 KM Biologics Company Information
  105. 8.18.2 KM Biologics Business Overview
  106. 8.18.3 KM Biologics Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  107. 8.18.4 KM Biologics Plasma Fractionation Technology Product Portfolio
  108. 8.18.5 KM Biologics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst